drugset / Trial / NCT06490653
Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this randonmized controlled trial, aim to compare the effectiveness of local administration of tranexamic acid and blood stopper (Ankaferd®) on cessation of bleeding in epistaxis patients.
Timeline
- Start
- 2024-10
- Primary completion
- 2025-10
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ankaferd | Unknown | 5 ml | Intranasal |
Indications
No indication recorded.